1-3 of 3
Liza DeAnnuntis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Diarrhea on Health-Related Quality of Life: Analysis of the Phase 3 BFORE Trial of Bosutinib Vs Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Tim H Brümmendorf, MD, Carla M. Mamolo, PhD, Arlene Reisman, Andrew G Bushmakin, Joseph C Cappelleri, PhD MPH, MS, Rocco J. Crescenzo, DO, FACOI, Liza DeAnnuntis, Andrea Viquiera, Jorge E. Cortes, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4264.
https://doi.org/10.1182/blood-2018-99-110152
Published: 2018
Journal Articles

Pregnancy Outcomes in Patients Treated with Bosutinib

Jorge E. Cortes, MD, Carlo Gambacorti-Passerini, MD, Michael W. Deininger, MD PhD, Elisabetta Abruzzese, Liza DeAnnuntis, Tim H Brümmendorf, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1729.
https://doi.org/10.1182/blood-2018-99-110547
Published: 2018
Journal Articles

Bosutinib in Newly Diagnosed Chronic Myeloid Leukemia (CML): Gastrointestinal (GI), Liver, and Hematological Safety Characterization in the BFORE Trial

Michael J. Mauro, MD, Carlo Gambacorti-Passerini, MD, Michael W. Deininger, MD PhD, Charles Chuah, MD, Dong-Wook Kim, MD PhD, Iryna Dyagil, MDPhD, Natalia Glushko, Dragana Milojkovic, MBBS, PhD, Philipp D. le Coutre, MD, Valentín García Gutiérrez, PhD, Laurence Reilly, Allison Jeynes-Ellis, Rocco J. Crescenzo, DO, FACOI, Roberto Uehara, Eric Leip, PhD, Liza DeAnnuntis, Nathalie Bardy-Bouxin, PhD, Andreas Hochhaus, MD, Timothy H. Brümmendorf, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1620.
https://doi.org/10.1182/blood.V130.Suppl_1.1620.1620
Published: 2017